Battiston L, Tulissi P, Moretti M, Mazzoran L, Marchi P, Pussini E, Pozzato G
Institute of Medicina Clinica, University of Trieste, School of Medicine, Italy.
Pharmacol Res. 1995 May;31(5):305-11. doi: 10.1016/1043-6618(95)80036-0.
As a fraction of ingested ethanol (EtOH) is metabolized by gastric mucosa, different amounts of alcohol reach the liver, when the same dose is administered by oral or intravenous route. In previous experiments, we demonstrated that the decrease of hepatic reduced glutathione (GSH) is less pronounced and is followed by a quicker recovery after oral than after intraperitoneal administration of the same amount of EtOH. Therefore, the time-course of hepatic GSH concentration seems to be an indirect assay of EtOH metabolism by the liver. On the basis of these findings, any condition causing a reduced function of gastric alcohol dehydrogenase (ADH) should show up as a more severe depletion of hepatic GSH. In the same rat experimental model we determined the effects of cimetidine and omeprazole administration on gastric ADH activity and on the time-course of hepatic GSH after EtOH load. Cimetidine was shown to inhibit gastric ADH with a Ki of 0.167 +/- 0.009 mmol l-1; accordingly, the pretreatment with this drug (20 mg kg-1 b.w. per day for 1 week) determined, after oral EtOH load, a marked reduction of hepatic GSH, likewise after intraperitoneal administration. Omeprazole exerted only a marginal inhibition on gastric ADH and this drug (0.3 mg kg-1 b.w. per day for 1 week) did not modify the time-course of hepatic GSH concentrations after EtOH load. This study indicates that the inhibition of gastric ADH, when associated with EtOH intake, induces depletion of the hepatic GSH concentration and, therefore, possible liver damage.
由于摄入的乙醇(EtOH)有一部分会被胃黏膜代谢,所以当通过口服或静脉途径给予相同剂量的乙醇时,到达肝脏的乙醇量是不同的。在先前的实验中,我们证明,口服相同量的EtOH后,肝脏中还原型谷胱甘肽(GSH)的减少不如腹腔注射后明显,且随后恢复得更快。因此,肝脏GSH浓度的时间进程似乎是肝脏对EtOH代谢的一种间接检测方法。基于这些发现,任何导致胃乙醇脱氢酶(ADH)功能降低的情况都应表现为肝脏GSH更严重的消耗。在相同的大鼠实验模型中,我们测定了给予西咪替丁和奥美拉唑对胃ADH活性以及EtOH负荷后肝脏GSH时间进程的影响。结果显示,西咪替丁对胃ADH有抑制作用,其抑制常数Ki为0.167±0.009 mmol l-1;因此,用该药物预处理(每天20 mg kg-1体重,持续1周)后,口服EtOH负荷会导致肝脏GSH显著降低,腹腔注射后也是如此。奥美拉唑对胃ADH仅有轻微抑制作用,且该药物(每天0.3 mg kg-1体重,持续1周)不会改变EtOH负荷后肝脏GSH浓度的时间进程。本研究表明,与EtOH摄入相关时,胃ADH的抑制会导致肝脏GSH浓度降低,进而可能造成肝损伤。